Ewelina B. Kulikowski,Dean E. Gilham,Sylwia Wasiak,Christopher R.A. Halliday
申请号：
US15066513
公开号：
US20160263126A1
申请日:
2016.03.10
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention comprises methods of modulating the complement cascade in a mammal and for treating and/or preventing diseases and disorders associated with the complement pathway by administering a compound of Formula I or Formula II, such as, for example, 2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one or a pharmaceutically acceptable salt thereof.
